^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Chronic Lymphocytic Leukemia |
| Drug: | Belrapzo (bendamustine RTD) (Alkylating agent) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
10/14/2021
Excerpt:
BELRAPZO is an alkylating drug indicated for treatment of patients with…Chronic lymphocytic leukemia (CLL). Efficacy relative to first line therapies other than chlorambucil has not been established.
